Frankfurt - Delayed Quote EUR
Vanda Pharmaceuticals Inc. (VM4.F)
3.7800
-0.0800
(-2.07%)
As of 8:04:42 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | 45.13M | 53.37M | 222.86M | 322.08M |
| Low Estimate | 41.4M | 49.61M | 218.57M | 297.8M |
| High Estimate | 49M | 56.5M | 225M | 348.44M |
| Year Ago Sales | -- | 50.47M | 198.77M | 222.86M |
| Sales Growth (year/est) | -- | 5.74% | 12.12% | 44.52% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| VM4.F | -- | -- | -- | -- |
| S&P 500 | 6.85% | 4.67% | 8.41% | 14.16% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/1/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 2/18/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/4/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/28/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/21/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/23/2024 |
Related Tickers
YB4P.SG Savara Inc
2.8000
-1.41%
NVV1.BE Novavax Inc
6.50
+15.66%
OMGAQ
0.0470
+42.42%
LVTX LAVA Therapeutics N.V.
1.3600
-1.45%
IMNN Imunon, Inc.
0.8766
+0.53%
INZY Inozyme Pharma, Inc.
0.9806
-4.80%
SVRA Savara Inc.
3.2500
+0.93%
IMRX Immuneering Corporation
1.4100
+2.17%
IMMP Immutep Limited
1.6200
+5.88%
TVRD Tvardi Therapeutics, Inc.
18.48
-5.18%